OpenURL Connection Search

Select item for more details and to access through your institution.

A ‘DNA replication’ signature of progression and negative outcome in colorectal cancer.
Published in:
2010
By:
- Pillaire, M-J;
- Selves, J;
- Gordien, K;
- Gourraud, P-A;
- Gentil, C;
- Danjoux, M;
- Do, C;
- Negre, V;
- Bieth, A;
- Guimbaud, R;
- Trouche, D;
- Pasero, P;
- Méchali, M;
- Hoffmann, J-S;
- Cazaux, C
Publication type:
Correction Notice
A ‘DNA replication’ signature of progression and negative outcome in colorectal cancer.
Published in:
Oncogene, 2010, v. 29, n. 6, p. 876, doi. 10.1038/onc.2009.378
By:
- Pillaire, M.-J.;
- Selves, J.;
- Gordien, K.;
- Gouraud, P.-A.;
- Gentil, C.;
- Danjoux, M.;
- Do, C.;
- Negre, V.;
- Bieth, A.;
- Guimbaud, R.;
- Trouche, D.;
- Pasero, P.;
- Méchali, M.;
- Hoffmann, J.-S.;
- Cazaux, C.
Publication type:
Article
The p400/Tip60 ratio is critical for colorectal cancer cell proliferation through DNA damage response pathways.
Published in:
Oncogene, 2009, v. 28, n. 12, p. 1506, doi. 10.1038/onc.2008.499
By:
- Mattera, L.;
- Escaffit, F.;
- Pillaire, M.-J.;
- Selves, J.;
- Tyteca, S.;
- Hoffmann, J.-S.;
- Gourraud, P.-A.;
- Chevillard-Briet, M.;
- Cazaux, C.;
- Trouche, D.
Publication type:
Article
Novel evidences for a tumor suppressor role of Rev3, the catalytic subunit of Pol ζ.
Published in:
Oncogene, 2008, v. 27, n. 47, p. 6093, doi. 10.1038/onc.2008.212
By:
- Brondello, J.-M.;
- Pillaire, M. J.;
- Rodriguez, C.;
- Gourraud, P.-A.;
- Selves, J.;
- Cazaux, C.;
- Piette, J.
Publication type:
Article
Characterization of promoter regulatory elements involved in downexpression of the DNA polymerase κ in colorectal cancer.
Published in:
Oncogene, 2007, v. 26, n. 23, p. 3387, doi. 10.1038/sj.onc.1210116
By:
- Lemée, F.;
- Bavoux, C.;
- Pillaire, M. J.;
- Bieth, A.;
- Machado, C. R.;
- Pena, S. D.;
- Guimbaud, R.;
- Selves, J.;
- Hoffmann, J. S.;
- Cazaux, C.
Publication type:
Article
In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery.
Published in:
Gene Therapy, 2007, v. 14, n. 9, p. 752, doi. 10.1038/sj.gt.3302920
By:
- Golzio, M.;
- Mazzolini, L.;
- Ledoux, A.;
- Paganin, A.;
- Izard, M.;
- Hellaudais, L.;
- Bieth, A.;
- Pillaire, M. J.;
- Cazaux, C.;
- Hoffmann, J. S.;
- Couderc, B.;
- Teissié, J.
Publication type:
Article
Cetuximab potentiates oxaliplatin cytotoxic effect through a defect in NER and DNA replication initiation.
Published in:
British Journal of Cancer, 2008, v. 98, n. 1, p. 120, doi. 10.1038/sj.bjc.6604134
By:
- Balin-Gauthier, D.;
- Delord, J.-P.;
- Pillaire, M.-J.;
- Rochaix, P.;
- Hoffman, J.-S.;
- Bugat, R.;
- Cazaux, C.;
- Canal, P.;
- Allal, B. C.
Publication type:
Article

Found: 7

A ‘DNA replication’ signature of progression and negative outcome in colorectal cancer.

A ‘DNA replication’ signature of progression and negative outcome in colorectal cancer.

The p400/Tip60 ratio is critical for colorectal cancer cell proliferation through DNA damage response pathways.

Novel evidences for a tumor suppressor role of Rev3, the catalytic subunit of Pol ζ.

Characterization of promoter regulatory elements involved in downexpression of the DNA polymerase κ in colorectal cancer.

In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery.

Cetuximab potentiates oxaliplatin cytotoxic effect through a defect in NER and DNA replication initiation.